Product Information
MAPAP COLD FORMULA CAPLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0937 per EA under NDC 00904578624. Its NADAC has been published 523 times since Nov 28, 2013.
Strength
325; 10; 5 mg/1; mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904578624
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/15/2005
Pharmacological Classes
Price Statistics
The NADAC for MAPAP COLD FORMULA CAPLET has been published 523 times since Nov 28, 2013, and over the history we have for it it has risen 28.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0937 per EA |
|---|---|
| All-time high | $0.0985 (Oct 16, 2024) |
| All-time low | $0.0654 (Jul 19, 2017) |
| 52-week high | $0.0970 |
| 52-week low | $0.0903 |
| Median price | $0.0907 |
| Average price | $0.0890 |
| Largest weekly change | +24.3% (Mar 19, 2014) |
| Weeks tracked | 523 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MAPAP COLD FORMULA CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for MAPAP COLD FORMULA CAPLET, manufactured by Major Pharmaceuticals, is $0.0937 per EA (NDC 00904578624), effective Sep 30, 2026.
How has the price of MAPAP COLD FORMULA CAPLET changed over time?
Over the history we have for it, the NADAC for MAPAP COLD FORMULA CAPLET has risen 28.5%. It has been tracked across 523 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MAPAP COLD FORMULA CAPLET?
Since Nov 28, 2013, the NADAC for MAPAP COLD FORMULA CAPLET has ranged from a low of $0.0654 (Jul 19, 2017) to a high of $0.0985 (Oct 16, 2024), with a median of $0.0907 per EA.
Are there cheaper alternatives to MAPAP COLD FORMULA CAPLET?
No other NADAC-published product currently shares the active ingredient and strength of MAPAP COLD FORMULA CAPLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MAPAP COLD FORMULA CAPLET?
MAPAP COLD FORMULA CAPLET (NDC 00904578624) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.